PCN41 COST-SAVINGS ASSOCIATED WITH BEVACIZUMAB PLUS...

PCN41 COST-SAVINGS ASSOCIATED WITH BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) COMPARED WITH CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CVC) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER (NSCLC) IN GERMANY

D Heigener, HG Bischoff, C Wiesner, R Aultman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)74292-3
File:
PDF, 92 KB
english, 2009
Conversion to is in progress
Conversion to is failed